Publication: Soluble TRAIL and BAFF Levels in Multiple Sclerosis During Interferon-Beta Therapy
| dc.contributor.author | Kurne, Ash | |
| dc.contributor.author | Aydin, Oemer Faruk | |
| dc.contributor.author | Guec, Dicle | |
| dc.contributor.author | Sayat, Gueliz | |
| dc.contributor.author | Canpinar, Hande | |
| dc.contributor.author | Yoeruebulut, Mehmet | |
| dc.contributor.author | Karabudak, Rana | |
| dc.date.accessioned | 2020-06-21T15:12:57Z | |
| dc.date.available | 2020-06-21T15:12:57Z | |
| dc.date.issued | 2008 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | [Kurne, Ash -- Sayat, Gueliz -- Karabudak, Rana] Hacettepe Univ Hosp, Dept Neurol, Neuroimmunol Unit, Ankara, Turkey -- [Aydin, Oemer Faruk] Ondokuz Mayis Univ, Fac Med, Dept Pediat, Samsun, Turkey -- | en_US |
| dc.description.abstract | … | en_US |
| dc.identifier.endpage | 138 | en_US |
| dc.identifier.issn | 0165-5728 | |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 137 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/19141 | |
| dc.identifier.volume | 203 | en_US |
| dc.identifier.wos | WOS:000261270600038 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science BV | en_US |
| dc.relation.journal | Journal of Neuroimmunology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Soluble TRAIL and BAFF Levels in Multiple Sclerosis During Interferon-Beta Therapy | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
